$RNN Ocuphire Pharma, Inc. Insider Trading Week 45/2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Ocuphire Pharma, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Ocuphire Pharma, Inc. in week 45/2020.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Nov 13 2020 | RNN | Ocuphire Pharma, I ... | Ainsworth Sean | Option Exercise | A | 4.05 | 5,000 | 20,250 | 5,000 | ||
Nov 13 2020 | RNN | Ocuphire Pharma, I ... | Rodgers Richard J | Option Exercise | A | 4.05 | 50,000 | 202,500 | 50,000 | ||
Nov 13 2020 | RNN | Ocuphire Pharma, I ... | Sooch Mina | President and CEO | Option Exercise | A | 4.05 | 130,000 | 526,500 | 130,000 | |
Nov 13 2020 | RNN | Ocuphire Pharma, I ... | MANUSO JAMES S J | Option Exercise | A | 4.05 | 5,000 | 20,250 | 5,000 | ||
Nov 13 2020 | RNN | Ocuphire Pharma, I ... | Gallagher Cam | Option Exercise | A | 4.05 | 5,000 | 20,250 | 5,000 | ||
Nov 13 2020 | RNN | Ocuphire Pharma, I ... | Hoffmann Bernhard | VP of Corp. Dev. & ... | Option Exercise | A | 4.05 | 20,000 | 81,000 | 20,000 | |
Nov 13 2020 | RNN | Ocuphire Pharma, I ... | MEYER ALAN R | Option Exercise | A | 4.05 | 7,500 | 30,375 | 7,500 | ||
Nov 13 2020 | RNN | Ocuphire Pharma, I ... | MEYER ALAN R | Option Exercise | A | 4.05 | 7,500 | 30,375 | 7,500 | ||
Nov 09 2020 | RNN | Ocuphire Pharma, I ... | MANUSO JAMES S J | Director | Option Exercise | A | 1.21 | 52,825 | 63,918 | 52,825 | |
Nov 09 2020 | RNN | Ocuphire Pharma, I ... | MANUSO JAMES S J | Director | Option Exercise | A | 0.90 | 35,663 | 32,097 | 35,663 | |
Nov 09 2020 | RNN | Ocuphire Pharma, I ... | MANUSO JAMES S J | Director | Grant | A | 0.00 | 10,136 | 0 | 10,136 | 0 to 10.1 K |
Nov 09 2020 | RNN | Ocuphire Pharma, I ... | Gallagher Cam | Director | Option Exercise | A | 1.21 | 52,825 | 63,918 | 52,825 | |
Nov 09 2020 | RNN | Ocuphire Pharma, I ... | Gallagher Cam | Director | Option Exercise | A | 0.90 | 35,663 | 32,097 | 35,663 | |
Nov 09 2020 | RNN | Ocuphire Pharma, I ... | Gallagher Cam | Director | Grant | A | 0.00 | 14,489 | 0 | 14,489 | 0 to 14.5 K |
Nov 09 2020 | RNN | Ocuphire Pharma, I ... | Ainsworth Sean | Director | Option Exercise | A | 1.21 | 52,825 | 63,918 | 52,825 | |
Nov 09 2020 | RNN | Ocuphire Pharma, I ... | Ainsworth Sean | Director | Option Exercise | A | 0.90 | 35,663 | 32,097 | 35,663 | |
Nov 09 2020 | RNN | Ocuphire Pharma, I ... | Ainsworth Sean | Director | Grant | A | 0.00 | 35,800 | 0 | 35,800 | 0 to 35.8 K |
Nov 09 2020 | RNN | Ocuphire Pharma, I ... | Hoffmann Bernhard | VP of Corp. Dev. an ... | Option Exercise | A | 1.65 | 4,226 | 6,973 | 4,226 | |
Nov 09 2020 | RNN | Ocuphire Pharma, I ... | Hoffmann Bernhard | VP of Corp. Dev. an ... | Option Exercise | A | 1.21 | 30,110 | 36,433 | 30,110 | |
Nov 09 2020 | RNN | Ocuphire Pharma, I ... | Hoffmann Bernhard | VP of Corp. Dev. an ... | Option Exercise | A | 0.90 | 42,867 | 38,580 | 42,867 | |
Nov 09 2020 | RNN | Ocuphire Pharma, I ... | Hoffmann Bernhard | VP of Corp. Dev. an ... | Grant | A | 0.00 | 100,120 | 0 | 100,120 | 0 to 100.1 K |
Nov 09 2020 | RNN | Ocuphire Pharma, I ... | Sooch Mina | President and CEO | Option Exercise | A | 1.21 | 158,475 | 191,755 | 158,475 | |
Nov 09 2020 | RNN | Ocuphire Pharma, I ... | Sooch Mina | President and CEO | Option Exercise | A | 0.90 | 178,284 | 160,456 | 178,284 | |
Nov 09 2020 | RNN | Ocuphire Pharma, I ... | Sooch Mina | President and CEO | Grant | A | 0.00 | 788,520 | 0 | 788,520 | 0 to 788.5 K |